Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19
Open Access
- 3 November 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (21), 8234
- https://doi.org/10.3390/ijms21218234
Abstract
Progressive respiratory failure is seen as a major cause of death in severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-induced infection. Relatively little is known about the associated morphologic and molecular changes in the circulation of these patients. In particular, platelet and erythrocyte pathology might result in severe vascular issues, and the manifestations may include thrombotic complications. These thrombotic pathologies may be both extrapulmonary and intrapulmonary and may be central to respiratory failure. Previously, we reported the presence of amyloid microclots in the circulation of patients with coronavirus disease 2019 (COVID-19). Here, we investigate the presence of related circulating biomarkers, including C-reactive protein (CRP), serum ferritin, and P-selectin. These biomarkers are well-known to interact with, and cause pathology to, platelets and erythrocytes. We also study the structure of platelets and erythrocytes using fluorescence microscopy (using the markers PAC-1 and CD62PE) and scanning electron microscopy. Thromboelastography and viscometry were also used to study coagulation parameters and plasma viscosity. We conclude that structural pathologies found in platelets and erythrocytes, together with spontaneously formed amyloid microclots, may be central to vascular changes observed during COVID-19 progression, including thrombotic microangiopathy, diffuse intravascular coagulation, and large-vessel thrombosis, as well as ground-glass opacities in the lungs. Consequently, this clinical snapshot of COVID-19 strongly suggests that it is also a true vascular disease and considering it as such should form an essential part of a clinical treatment regime.Keywords
This publication has 42 references indexed in Scilit:
- Flow cytometric analysis of platelets type 2 diabetes mellitus reveals âangryâ plateletsCardiovascular Diabetology, 2016
- Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastographyÂŽ studyCardiovascular Diabetology, 2015
- Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cellsMetallomics, 2014
- A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopyToxicology Mechanisms and Methods, 2013
- The adaptability of red blood cellsCardiovascular Diabetology, 2013
- Interaction of Fibrin with Red Blood Cells: The Role of IronUltrastructural Pathology, 2012
- Comparison of Two Platelet Activation Markers Using Flow Cytometry After In Vitro Shear Stress Exposure of Whole Human BloodArtificial Organs, 2010
- Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinsonâs, Huntingtonâs, Alzheimerâs, prions, bactericides, chemical toxicology and others as examplesArchives of Toxicology, 2010
- Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesBMC Medical Genomics, 2009
- Inflammatory roles of P-selectin.JCI Insight, 1993